Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nederman signs agreements worth around SEK 50 million with the Zhongwang Aluminium Group, China

Nederman has signed agreements to supply the Zhongwang Aluminium Group with complete solutions for filtrating fumes from the aluminum smelting furnaces to be installed at their new plant in northern China. The agreements cover several installations and are worth totally around SEK 50 million. The first sub-order worth around SEK 20 million has been received.The Zhongwang Aluminium Group is one of the largest enterprises for supplying aluminium profiles in the world. The order includes the design and complete turnkey supply of Nederman filters and coolers, engineered and produced by the

Sale of the Summer

Leading ferry company, Stena Line has just announced details of a truly exceptional three-day-return fare available on their Belfast – Cairnryan route starting at just £179 for a car and up to five persons* (travelling Monday – Thursday, additional passengers £10 each return).  The not-to-be-missed fare is great news for anyone planning a trip to see relatives or friends, to enjoy a relaxing short-break or take in the excitement of a sporting occasion, as Diane Poole OBE, Head of Stena Line’s PR and Communications, explains:  “This really is the sale of the summer. If five people travel

ContextVision presents Q2 2013 report

Q2 HIGHLIGHTS · New major ultrasound customer signed · ContextVision wins important court ruling regarding patent litigation against Sapheneia. Q2 FINANCIAL DATA · Sales of 14.0 MSEK (16.0) · Operating result of -1.9 MSEK (-3.0) and operating margin of -13.3% (-18.7%). · Earnings per share of -0,18 (-0,37) SEK A video presentation by CEO Anita Tollstadius will be released on Friday, Aug 23:rd. Please follow the link: www.abiliteam.se/contextvisionQ22013

Pantar Amsterdam opts for Hybrid Managed Cloud Services from Proact

Complete facilitation of the data management platform, with 24x7 operations Pantar Amsterdam, a specialist in taking over organizational processes with repetitive tasks, has opted for a data management environment completely facilitated by Proact. The solution consists of Storage as a Service on the basis of data replications to an external secondary data centre.Quote from Pantar Amsterdam: Martijn Boontje “The solution we opted for from Proact fits together seamlessly with our vision to grow towards a completely ICT-managed organisation.” Within this completely managed and monitored

C-RAD Investor Presentations

C-RAD is informing about two upcoming events for current and potential investors.   Lunch Presentation at Erik Penser Bankaktiebolaget / Stockholm Date: September 2nd 2013/ kl. 12:00 Venue: Erik Penser, Biblioteksgatan 9; Stockholm Topic: C-RAD Half-Year Report Further information: Erik Penser Website  Please note: Registration latest August 29th 2013 via email to seminarium@penser.se                   C-RAD Investor Day / Uppsala Date: September 27th 2013/ kl. 14:00 till kl. 17:00

Production resumed on Huntington

Stavanger, 22 August 2013: Reference is made to the press release dated 12 August regarding the shut in of production from the Huntington field.Noreco has been informed by the operator of the Huntington Field, E.ON UK E&P, that production was restarted on 19 August 2013 following the precautionary shutdown due to concerns with the cargo tank venting activities during low wind conditions. As was previously announced, Huntington production was temporarily shut-in on 8 August 2013. Only small volumes have been produced since 19 August, and output is still subject to weather conditions.

Q-FREE ASA - MANDATORY NOTIFICATION OF TRADE

President and CEO, Øyvind Isaksen has on the 21 August purchased 5,847 QFR shares at an average price of NOK 17.20. New holding of QFR shares after the transaction is 125,836. Isaksen holds 675,000 share options in Q-Free ASA. CFO, Roar Østbø has on the 21 August purchased 10,000 QFR shares at an average price of NOK 17.08. New holding of QFR shares after the transaction is 84,000. Østbø holds 150,000 share options in Q-Free ASA. Board member, Selma Kveim has on the 21 August purchased 5,500 QFR shares at an average price of NOK 17.20. New holding of QFR shares after the transaction

SUMMARY OF INTERIM REPORT JANUARY - JUNE 2013

· Net profit was KSEK -3,621 kSEK (-3,137) and earnings per share to SEK -0.26 (-0.30). · The Group sale was KSEK 777 (1,083). · Cash and cash equivalents was KSEK 25,805 (41,178) at June 30th 2013. · Investments were during period KSEK 11,191 (12,317). · Equity was 109,996 KSEK (113,584) at June 30th 2013.   THE CURRENT PERIOD (3 months, April - June) · Net profit was KSEK -1,236 (-979) and earnings per share to SEK -0.09 (-0.09). · The Group sale was of KSEK 27 (250). · Investments during period April – June were KSEK 7,482 (1,811). · Sotkamo Silver has

Alfa Laval wins SEK 185 million energy-efficiency order in India

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won an order to supply Alfa Laval Packinox heat exchangers to a petrochemical plant in India. The order is booked in the Process Industry segment and has a value of approximately SEK 185 million. Deliveries are scheduled for 2013 and 2014.The Alfa Laval Packinox heat exchangers will be used in the production of mixed Xylenes, ingredients in the manufacturing of synthetic nylons and PET bottles. “This is the second large order, within a short period of time, for our highly energy-efficient Alfa

Skanska signs contract for next phase of Novartis Cambridge Campus Expansion Project, USA, worth USD 130 M, about SEK 848 M

Skanska has signed a contract for the next phase of work with existing client Novartis for the expansion of its pharmaceutical research campus located in Cambridge, MA, USA. The contract value is USD 130 M, about SEK 848 M, which will be included in order bookings for Skanska USA Building for the third quarter of 2013.Work on the project began in 2012 and is scheduled to be completed in 2015. Skanska USA is one of the leading development and construction companies in the country, consisting of four business units: Skanska USA Building, which specializes in building construction; Skanska

Interim Report, 1 January – 30 June 2013*

Q2 2013 (April – June) Remaining Group operations, excluding Cross Pharma · Net turnover totalled SEK 40.7 million (SEK 39.0 m). · The profit/loss after tax was SEK -63.7 million (SEK -65.4 m). · Basic and diluted earnings per share totalled SEK -2.04 (SEK -2.09). · The cash flow from operating activities amounted to SEK -8.3 million (SEK -5.2 m), while liquid assets and short-term investments totalled SEK 279.9 million (SEK 409.6 m) at the end of the period. First six months (January – June) Remaining Group operations, excluding Cross Pharma · Net turnover totalled

Finnish researchers develop quick test kit for detecting phenolic compounds in drinking water

Phenolic compounds a problem in industrialised countriesClean drinking water is a diminishing natural resource in developing nations and in many industrialised countries. VTT Technical Research Centre of Finland has developed a simple and inexpensive test kit that detects phenolic compounds in water. Sources of phenolic compounds found in drinking water include industrial wastewaters, drug residues and pipes. Certain phenolic compounds are toxic and some may even cause cancer. The method developed by VTT is based on a chemical reaction. A small test stick determines whether or not a

Purchase of own shares to cover social security fees related to incentive program

STOCKHOLM - August 22, 2013. The Board of Directors of Karolinska Development has decided – within the authorization from the Annual General Meeting on May 14, 2013 – to purchase a maximum of 93,685 shares of Series B.The purchase will be made from August 28, 2013 to May 13, 2014, which is the day before the Annual General Meeting 2014. The purchase of shares shall take place on NASDAQ OMX Stockholm and may only occur at a price within the share price interval registered at that time. The share price interval is the price interval between the highest buying price and the lowest selling

Etteplan Oyj's Board of Directors' new release

ETTEPLAN OYJ, STOCK EXCHANGE RELEASE, AUGUST 22, 2013, AT 09:30 A.M. ETTEPLAN OYJ’S BOARD OF DIRECTORS’ NEWS RELEASE Etteplan Oyj (“Etteplan”) has on August 19, 2013 disclosed that Ingman Group Oy Ab (“Ingman Group”) is under obligation to launch a mandatory takeover bid for the shares in Etteplan.  Ingman Group has informed that the cash consideration to be offered in the mandatory takeover bid will be EUR 3.20 for each share in Etteplan, which corresponds to the highest price paid by Ingman Group for Etteplan’s share during the six months’ time before the obligation to launch a

Photocure ASA - Results for the second quarter and first half 2013

Oslo, Norway, 22 August 2013: Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, today announces its results for the second quarter and first half 2013. Highlights include: (Numbers in brackets are for the corresponding period in 2012) ·         Total sales revenues of Hexvix/Cysview increased 27% to NOK 21 million (NOK 16 million) in the second quarter driven by continued strong underlying customer demand in key markets. ·         Total revenues of NOK 22 million in the second quarter were lower

Hexagon Composites ASA : Report Q2 and first half year 2013

The Hexagon Group achieved a turnover of NOK 713.8 (550.6) million and an operating profit before depreciation (EBITDA) of NOK 123.0 (66.2) million in the first half year of 2013. Operating profit (EBIT) was NOK 89.2 (33.1) million and profit before tax was NOK 88.0 (29.6) million. The first half year of 2013 were a pleasing period for Hexagon Composites with an overall increase in turnover and positive results in all business units. The first half year of 2013 therefore showed significant improvements compared to the first half year of 2012. The second quarter of 2013 provided a

Hexagon Composites consider strategic options

Hexagon Composites' wholly-owned subsidiary Hexagon Devold, which manages the Composite Reinforcements business area, has in recent years carried out significant cost-cutting measures. This has essentially been done by the closure of operations in Norway, the development of low-cost capacity in Lithuania and the United States and increased focus on procurement. These measures have improved the company's competitiveness and increased its market share. Deficits have been turned to a profit in the first half of 2013. The composite reinforcements sector is facing structural changes and

Standard & Poor’s Ratings Services has upgraded Metsä Board's credit rating

Metsä Board Corporation Stock Exchange Release 22 August 2013 at 9 am EET Standard & Poor’s Ratings Services upgraded on 21 August 2013 Metsä Board Corporation's B- rating to B. The outlook of the rating is stable. Upgrade does not have an impact on Metsä Board’s current annual financing costs. METSÄ BOARD CORPORATION Further information:Matti Mörsky, CFO, tel. +358 10 465 4913Henri Sederholm, Vice President, Group Controller, tel. +358 10 465 5145

BioGaia AB Interim report 1 January – 30 June 2013

President’s comments: “The efforts to break into the major markets are starting to pay off. In the second quarter we signed an agreement with the state-owned company Beijing Keyuan Xinhai Pharmaceutical in China”, says Peter Rothschild, President of BioGaia AB. “To a large extent, our sales work is focused on the large highly populated countries and we hope that these activities will result in new agreements and relatively rapid launches during the current and coming year. We remain committed to achieving continued healthy growth in sales, both through increased sales among our

More efficient and economical capture of power plant carbon dioxide emissions

A consortium led by VTT Technical Research Centre of Finland has developed a new technology that captures the carbon dioxide emissions of power plants more economically and ecologically. The International Energy Agency IEA regards carbon dioxide capture as essential if the emission reduction targets set for greenhouse gases are to be met. The new technology is based on a combination of traditional circulating fluidised bed combustion and oxyfuel combustion, enabling more extensive use of cheaper fuels and even biomass. Political decisions and legislative changes will be necessary before

Fingerprint Cards (FPC) recruits Country Manager in Japan

Takeshi Murakami has been appointed FPC Country Manager Japan. He joins the company from Authentec Inc. where he held the position as Senior Sales Manager Japan, and was responsible for sales into mobiles, tablets, PCs and other IT products for all major OEM customers in Japan. Since the local office in Tokyo opened in January 2013, FPC’s activities in Japan have increased significantly. Due to quickly growing awakened interest in biometric products and systems in Japan, we are now expanding the existing team to include a sales and marketing function. The establishment of this function

Karolinska Development AB (publ) ― Interim report January - June 2013

STOCKHOLM – August 22, 2013. Karolinska Development AB (publ) announces publication of its Interim report January-June, 2013. A conference call will be held today at 15.00 CET. Participant access numbers: SE: +46 (0) 8 506 307 79, UK: +44 (0) 1452 555 131, or US: +1 866 682 8490. The full report and a link to the webcast are available on the company's website.Torbjörn Bjerke, CEO, comments: ”The progress in Karolinska Development’s active company portfolio remains strong. Since the first quarter 2013, positive clinical data have been presented for four projects. Our focus on business

Sobi submits application for Orfadin® oral suspension to EMA

Swedish Orphan Biovitrum AB (publ) (Sobi) announced today that the company'sapplication for Orfadin oral suspension has been validated by the EuropeanMedicines Agency (EMA). This new dosage form has been developed to facilitatethe ease and accuracy in administration of the desired Orfadin dose topaediatric patients and to increase convenience for the patients and theircaregivers. "We are glad that our application for the Orfadin oral suspension has beenaccepted by EMA", said Birgitte Volck, Senior Vice President and Chief MedicalOfficer at Sobi. "The liquid formulation of Orfadin

H+H International A/S - Interim financial report H1 2013

Company Announcement No. 287, 2013 Copenhagen, Denmark, 2013-08-22 07:54 CEST (GLOBE NEWSWIRE) --   H+H International A/SDampfærgevej 3, 3rd Floor2100 Copenhagen ØDenmarkTelephone: +45 35 27 02 00www.HplusH.com   Key figures for the period 1 January to 30 June 2013 · Second-quarter revenue was DKK 369 million (2012: DKK 339 million). First-half revenue was DKK 602 million (2012: DKK 612 million). · Second-quarter EBITDA was DKK 38 million (2012: DKK 38 million). First-half EBITDA was DKK 32 million (2012: DKK 42 million). · H+H made a profit before tax

There are no items matching the current filter
There are no more items matching the current filter
Back to top